HQ
Columbus, Ohio
Founded
2015
Founders and CEO
Margaret Groh, CEO
Chris Breuer, Co-Founder
Cameron Best, Co-Founder
Sector
Life Sciences

Company Profile

Lyst Therapeutics

Lyst Therapeutics is a project at Nationwide Children's Research Institute to determine the effect of LYST antibody on inhibiting the formation of tissue engineered vascular graft stenosis.

Lyst Therapeutics in the News

Nationwide Children’s Hospital Reports New Highs in Tech Licensing Deals
Columbus Business First